Search results for

Under new rules, the top executives of those companies that seek federal bailout funds cannot earn more than $500,000. Steven Hall, managing director of Steven Hall and Partners, an executive compensation consultation firm, offers his insight on what the change means.

The U.S. government has again propped up insurance giant AIG. It's the fourth time the government has intervened to save the company. The question is whether an additional $30 billion, on top of the $150 billion already committed, will be enough to save the company. Some analysts believe government aid to AIG will peak at $250 billion.

Dorie Greenspan's quest for her friends' chocolate mousse recipe was the stuff of private-eye fiction. Yet she figured it out, and as a Valentine's gift, she passes the delectable mousse along to us.

Wall Street Journal economics writer David Wessel's new book, Red Ink, lays out in unsparing terms the way the U.S. government spends money, who pays what in taxes, and why politicians can't seem to agree on ways to reduce the potentially catastrophic deficit.

The unassuming, 45-year-old Sergio Moro has jailed many of Brazil's rich and powerful, formerly presumed unimpeachable. Moro plays down accolades but some want him to run for president.

The top-ranked U.S. team is returning to the Women's World Cup final for a third straight time after defeating England 2-1 Tuesday. They'll take on either the Netherlands or Sweden on Sunday.

This holiday season, instead of settling for the standard martini, historian Lesley Blume suggests you reach for a taste of bygone cocktail culture. She offers tips for picking the right antique elixir, as well as the original recipe for one of Ernest Hemingway's favorites.

NPR's A Martinez speaks with Ben Rothenberg, co-host of the podcast No Challenges Remaining, about the Australian Open finals.

California holds an open primary Tuesday — meaning candidates from both parties run together with the top two advancing. Candidates are vying to replace the late Sen. Dianne Feinstein.

Drugmakers make big profits in the U.S. But many pay taxes far below the 21% corporate tax rate. Pfizer's effective tax rate is so low it's getting a big refund despite booking $59 billion in revenue.